Remus Pharmaceuticals Limited — Others, 07-01-2025: Quarterly Compliance Report on Corporate governance - within 21 days from the end of the quarter

Remus Pharmaceuticals has confirmed its non-applicability to the Corporate Governance Report requirements under Regulation 27(2) of SEBI listing regulations due to its listing on the SME Emerge Platform. This exemption alleviates the company from the burden of filing the quarterly and half-year Corporate Governance Reports.

Investors may view this development positively, as it could allow Remus to focus more resources on operational growth and strategic initiatives without the additional compliance responsibilities, potentially enhancing operational efficiency.